Holen Sie sich die Stockscreener-App
824.35
0.82%
-4.495
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$828.84
Offen:
$834.13
24-Stunden-Volumen:
144.79K
Relative Volume:
0.13
Marktkapitalisierung:
$96.51B
Einnahmen:
$403.43B
Nettoeinkommen (Verlust:
$5.10B
KGV:
21.43
EPS:
38.4657
Netto-Cashflow:
$5.41B
1W Leistung:
+3.22%
1M Leistung:
+10.36%
6M Leistung:
+0.61%
1J Leistung:
+15.86%
1-Tages-Spanne:
$821.95
$840.00
1-Wochen-Bereich:
$804.12
$861.00
52-Wochen-Spanne:
$637.00
$999.00
Mckesson Corp Stock (MCK) Company Profile
Firmenname
Mckesson Corp
Sektor
Branche
Telefon
972-446-4800
Adresse
6555 STATE HIGHWAY 161, IRVING, TX
Compare MCK vs COR, CAH, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MCK
Mckesson Corp
|
824.32 | 97.35B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
302.68 | 59.14B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
226.51 | 52.87B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
84.81 | 9.82B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.47 | 1.35B | 14.85M | -136.07M | 7.25M | -0.4726 |
Mckesson Corp Stock (MCK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2024-12-04 | Fortgesetzt | Mizuho | Neutral |
| 2024-11-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-09-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-09-05 | Bestätigt | Leerink Partners | Outperform |
| 2024-08-08 | Bestätigt | Mizuho | Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-31 | Eingeleitet | Citigroup | Buy |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-07-06 | Herabstufung | Argus | Buy → Hold |
| 2022-06-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-02-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-11-02 | Bestätigt | Barclays | Overweight |
| 2021-11-02 | Bestätigt | BofA Securities | Buy |
| 2021-11-02 | Bestätigt | Evercore ISI | Outperform |
| 2021-11-02 | Bestätigt | Jefferies | Buy |
| 2021-03-30 | Hochstufung | Argus | Hold → Buy |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-08-04 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-05-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-18 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-13 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-01-10 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-05 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-07-22 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-10-26 | Bestätigt | Barclays | Equal Weight |
| 2018-07-20 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-05-29 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-02 | Bestätigt | Mizuho | Neutral |
| 2018-01-24 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Mckesson Corp Aktie (MCK) Neueste Nachrichten
McKesson raises quarterly dividend 15% to $0.94 per share - Investing.com
McKesson Marks 10th Straight Year of Dividend Growth With $0.94 Payout - Stock Titan
McKesson Corp. stock underperforms Monday when compared to competitors - MarketWatch
MCKC Bond Profile — Key Metrics - TradingView
US581557BY0 Bond Profile — Key Metrics - TradingView
McKesson's Q1 2027 Earnings: What to Expect - Barchart.com
McKesson (MCK) Stock Forecast and Price Target 2026 $MCK - MarketBeat
LLY5600584 Bond Profile — Key Metrics - TradingView
A Look at McKesson Corp (MCK) After 5.7% Gain -- GF Value $794.8 - GuruFocus
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
LLY5237191 Bond Profile — Key Metrics - TradingView
Jonathan Jackson from Illinois’s 1st district makes trades in Hilton, McKesson, and Sphere Entertainment stocks - Investing.com
Here’s Why McKesson Corporation (MCK) Slid in Q2 - Yahoo Finance
McKesson: Embedding Impact and Purpose Across Operations - Healthcare Digital
XS156717452 Bond Profile — Key Metrics - TradingView
LLY6082068 Bond Profile — Key Metrics - TradingView
McKesson (MCK) Stock Dips While Market Gains: Key Facts - Yahoo Finance
McKesson Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
US581557BC8 Bond Profile — Key Metrics - TradingView
McKesson stock holds steady as healthcare distribution scale anchors long-term appeal - Ad-hoc-news.de
Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry - Yahoo Finance
A19WCE Bond Profile — Key Metrics - TradingView
US581557BT1 Bond Profile — Key Metrics - TradingView
McKesson Stock (MCK) Opinions on Political Stock Purchases - Quiver Quantitative
US581557BX2 Bond Profile — Key Metrics - TradingView
McKesson publishes Impact Report with key milestones - HME News
MCK.GL Bond Profile — Key Metrics - TradingView
McKesson (MCK) Falls After CEO Share Sale, Is The 14% Discount Enough? - Yahoo Finance
McKesson stock reflects steady healthcare distribution strength - ad-hoc-news.de
Ritchie John Torres purchases McKesson Corporation stock - Investing.com
McKesson (MCK) Stock Trades Down, Here Is Why - Yahoo Finance
McKesson Corporation's Stock Price Drops to $792.81, Experiencing a 3.16% Decline: An In-depth Analysis - Smartkarma
Is McKesson Corp (MCK) a Bargain After 3.2% Drop? GF Value Says Undervalued - GuruFocus
McKesson Falls as Investors Weigh Recent Leadership Changes and Prior Revenue Concerns - Quiver Quantitative
McKesson Corp. stock underperforms Thursday when compared to competitors - MarketWatch
McKesson's Oncology Leadership and Robust Free Cash Flow Underpin Strong Durable Fundamentals - Morningstar
Congressional Trading Report: Rep. Ritchie Torres Bought Over $1K In McKesson Stock - Benzinga
Brokers Suggest Investing in McKesson (MCK): Read This Before Placing a Bet - Yahoo Finance
Meet the Dallas 500: Brian Tyler, McKesson Corp. - D Magazine
McKesson CEO Brian Tyler sells $6.7 million in company shares - Investing.com
McKesson CEO Brian Tyler sells $6.7 million in company shares By Investing.com - Investing.com Nigeria
Form 4 McKesson For: 8 July By Investing.com - Investing.com Canada
McKesson (MCK) CEO’s 8,463-share sale executed under Rule 10b5-1 plan - Stock Titan
McKesson Checks All The Boxes To Survive And Prosper In A Weak Economy, But There's A Big Catch - Seeking Alpha
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
McKesson wound care portfoliodiscreet dressings for home patients - ad-hoc-news.de
McKesson (MCK) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Form 144 MCKESSON CORP For: 7 July By Investing.com - Investing.com Nigeria
McK (NYSE: MCK) Form 144 shows Brian S. Tyler plans to sell shares - Stock Titan
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026? - The Motley Fool
Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Finanzdaten der Mckesson Corp-Aktie (MCK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):